Philips completes cancellation of 4.4 million shares

19.06.24 13:00 Uhr

Werte in diesem Artikel
Aktien

24,04 EUR 0,22 EUR 0,92%

June 19, 2024

Amsterdam, the Netherlands – Royal Philips (NYSE: PHG; AEX: PHIA) today announced that it has completed the cancellation of 4,437,164 of its shares. The cancelled shares were acquired as part of the completed EUR 1.5 billion share repurchase program for capital reduction purposes that was announced on July 26, 2021.

Philips’ current issued share capital amounts to EUR 187,987,876.80 representing 939,939,384 common shares.

More information is available here

For further information, please contact:

Ben Zwirs
Philips External Relations
Tel.: +31 6 1521 3446
E-mail: ben.zwirs@philips.com

Dorin Danu
Philips Investor Relations
Tel.: +31 20 59 77055
E-mail: dorin.danu@philips.com

About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2023 sales of EUR 18.2 billion and employs approximately 69,100 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.

Forward-looking statements

This release contains certain forward-looking statements with respect to the financial condition, results of operations and business of Philips and certain of the plans and objectives of Philips with respect to these items. Examples of forward-looking statements include statements made about the strategy, estimates of sales growth, future EBITA, future developments in Philips’ organic business and the completion of acquisitions and divestments. By their nature, these statements involve risk and uncertainty because they relate to future events and circumstances and there are many factors that could cause actual results and developments to differ materially from those expressed or implied by these statements.


Ausgewählte Hebelprodukte auf Philips

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Philips

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Nachrichten zu Philips N.V.

Analysen zu Philips N.V.

DatumRatingAnalyst
09.07.2024Philips NeutralJP Morgan Chase & Co.
04.07.2024Philips BuyGoldman Sachs Group Inc.
03.07.2024Philips NeutralUBS AG
28.06.2024Philips NeutralJP Morgan Chase & Co.
25.06.2024Philips NeutralUBS AG
DatumRatingAnalyst
04.07.2024Philips BuyGoldman Sachs Group Inc.
07.06.2024Philips BuyGoldman Sachs Group Inc.
30.04.2024Philips OverweightBarclays Capital
30.04.2024Philips BuyGoldman Sachs Group Inc.
29.04.2024Philips OverweightBarclays Capital
DatumRatingAnalyst
09.07.2024Philips NeutralJP Morgan Chase & Co.
03.07.2024Philips NeutralUBS AG
28.06.2024Philips NeutralJP Morgan Chase & Co.
25.06.2024Philips NeutralUBS AG
02.05.2024Philips HaltenDZ BANK
DatumRatingAnalyst
07.05.2024Philips UnderperformJefferies & Company Inc.
29.04.2024Philips SellUBS AG
29.04.2024Philips UnderweightJP Morgan Chase & Co.
23.04.2024Philips UnderperformJefferies & Company Inc.
18.04.2024Philips UnderperformJefferies & Company Inc.

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Philips N.V. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"